Understanding Migraine Comorbidities, Treatment Implications and Opportunities
Managing Migraine: A Podcast Series
Release Date: 08/21/2025
The R.A.T.E Mnemonic: Recognize, Assess, Treat, Evaluate - Part 4 : Evaluate
Managing Migraine: A Podcast Series
In this episode Dr Short and Dr Ehrlich discusss the E of the RATE menmonic tool
info_outline
The R.A.T.E Mnemonic: Recognize, Assess, Treat, Evaluate - Part 3 : Treat
Managing Migraine: A Podcast Series
In this episode Dr Short and Dr Ehrlich discusss the T of the RATE menmonic tool
info_outline
The R.A.T.E Mnemonic: Recognize, Assess, Treat, Evaluate - Part 2 : Assess
Managing Migraine: A Podcast Series
In this episode Dr Short and Dr Ehrlich discusss the A of the RATE menmonic tool
info_outline
The RATE Mnemonic: Recognize, Assess, Treat, Evaluate - Part 1 : Recognize
Managing Migraine: A Podcast Series
In this episode Dr Short and Dr Ehrlich discusss the R of the RATE menmonic tool
info_outline
Understanding Migraine Comorbidities, Treatment Implications and Opportunities
Managing Migraine: A Podcast Series
In this podcast, Dawn Buse PhD, a clinical professor of neurology and licensed psychology, and Shoshana Lipson, a patient advocate, person living with migraine and the founder of Migraine Meanderings and Hope in Pain, discuss migraine comorbidities, treatment implications and opportunities. The speakers are consultants for Pfizer.
info_outline
Migraine and the Hidden Burden of Disability and Stigma
Managing Migraine: A Podcast Series
In this podcast, Dawn Buse PhD, a clinical professor of neurology and licensed psychology, and Shoshana Lipson, a patient advocate, person living with migraine and the founder of Migraine Meanderings and Hope in Pain, discuss migraine and the hidden burden of disability and stigma. The speakers are consultants for Pfizer.
info_outlineIn this podcast, Dawn Buse PhD, a clinical professor of neurology and licensed psychology, and Shoshana Lipson, a patient advocate, person living with migraine and the founder of Migraine Meanderings and Hope in Pain, discuss migraine comorbidities, treatment implications and opportunities. The speakers are consultants for Pfizer.